BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3065665)

  • 1. Peritonitis during continuous ambulatory peritoneal dialysis. Treatment with pefloxacin: first results and pharmacokinetics.
    Benzakour M; Lagarde C; Benevent D; Mounier M; Denis F
    Nephron; 1988; 50(2):175-6. PubMed ID: 3065665
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of peritonitis related to chronic ambulatory peritoneal dialysis (CAPD) using two daily intraperitoneal injections of 400 mg pefloxacin.
    Ragnaud JM; Roche-Bezian MC; Dupon M; Wone C
    Chemioterapia; 1987 Jun; 6(2 Suppl):481-3. PubMed ID: 3509476
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral pefloxacin mesylate in the treatment of continuous ambulatory peritoneal dialysis associated peritonitis: an open non-comparative study.
    Rose TF; Ellis-Pegler R; Collins J; Small M
    J Antimicrob Chemother; 1990 May; 25(5):853-9. PubMed ID: 2373667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of peritonitis in continuous ambulatory peritoneal dialysis with a combination of fosfomycin and pefloxacin].
    Michel C; Viron B; Delisle F; Lependoven C; Mignon F
    Pathol Biol (Paris); 1989 Apr; 37(4):269-71. PubMed ID: 2660079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of CAPD peritonitis with oral ciprofloxacin.
    Nephrol Dial Transplant; 1989; 4(8):759. PubMed ID: 2510089
    [No Abstract]   [Full Text] [Related]  

  • 6. Flavobacterial peritonitis in patients treated by peritoneal dialysis.
    Korzets Z; Maayan MC; Bernheim J
    Nephrol Dial Transplant; 1995; 10(2):280-3. PubMed ID: 7753467
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral pefloxacin in the treatment of CAPD peritonitis.
    Tan HW; Kon SP; Chua CT; Ngeow NF
    Med J Malaysia; 1992 Jun; 47(2):128-33. PubMed ID: 1494333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and dialysate levels of pefloxacin and its metabolites in CAPD patients with peritonitis.
    Rose TF; Bremner DA; Collins J; Ellis-Pegler R; Isaacs R; Richardson R; Small M
    J Antimicrob Chemother; 1990 Apr; 25(4):657-64. PubMed ID: 2351626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcal versus Staphylococcus epidermidis peritonitis in CAPD. A comparative study.
    Muñoz de Bustillo E; Aguilera A; Jiménez C; Bajo MA; Sánchez C; Selgas R
    Perit Dial Int; 1997; 17(4):392-5. PubMed ID: 9284469
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of peritonitis in kidney failure patients under continuous ambulatory peritoneal dialysis by pefloxacine. Results and pharmacokinetics].
    Denis F; Mounier M; Lagarde C; Benevent D
    Pathol Biol (Paris); 1987 May; 35(5):652-5. PubMed ID: 3302879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephalexin for the oral treatment of CAPD peritonitis.
    Drew PJ; Casewell MW; Desai N; Houang ET; Simpson CN; Marsh FP
    J Antimicrob Chemother; 1984 Feb; 13(2):153-9. PubMed ID: 6368518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bactericidal activity of a single daily dose of netilmicin in the treatment of CAPD-associated peritonitis.
    Anding K; Krumme B; Pelz K; Böhler J; Schollmeyer P
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):465-9. PubMed ID: 8937927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
    Fenton P
    J Antimicrob Chemother; 1984 May; 13(5):411-3. PubMed ID: 6735960
    [No Abstract]   [Full Text] [Related]  

  • 15. Cefoperazone in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients.
    Leehey DJ; Reid R; Chan AY; Ing TS
    Artif Organs; 1988 Dec; 12(6):482-3. PubMed ID: 3214327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin and CAPD peritonitis.
    Ludlam HA; Dryden MS; Phillips I
    J Antimicrob Chemother; 1991 May; 27(5):684-7. PubMed ID: 1885427
    [No Abstract]   [Full Text] [Related]  

  • 17. Acinetobacter peritonitis in patients receiving continuous ambulatory peritoneal dialysis.
    Valdez JM; Asperilla MO; Smego RA
    South Med J; 1991 May; 84(5):607-10. PubMed ID: 2035081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis.
    Lye WC; Lee EJ; van der Straaten J
    Perit Dial Int; 1993; 13 Suppl 2():S348-50. PubMed ID: 8399607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural defects in chronic peritoneal dialysis catheters contributing to peritonitis.
    Roxe DM; Santhanam S
    Nephron; 1983; 34(4):267-8. PubMed ID: 6877463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcome of Acinetobacter infections in CAPD patients.
    Lye WC; Lee EJ; Leong SO; Kumarasinghe G
    Perit Dial Int; 1994; 14(2):174-7. PubMed ID: 8043675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.